|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions

News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia


Company Profiles

Research Store

Research Events
Post an Event

Real Estate
Business Opportunities
|
|
|
|
|
PLoS By Category | Recent
PLoS Articles
|
|
Oncology - Pathology - Public Health and Epidemiology
|
Phosphorylation of LCRMP-1 by GSK3ß Promotes Filopoda Formation, Migration and Invasion Abilities in Lung Cancer Cells
Published:
Tuesday, February 21, 2012
Author:
Wen-Lung Wang et al.
by Wen-Lung Wang, Tse-Ming Hong, Yih-Leong Chang, Chen-Tu Wu, Szu-Hua Pan, Pan-Chyr Yang
LCRMP-1, a novel isoform of CRMP-1, can promote cancer cell migration, invasion and associate with poor clinical outcome in patients with non-small-cell lung cancer (NSCLC). However, the underlying regulatory mechanisms of LCRMP-1 in cancer cell invasiveness still remain obscure. Here, we report that GSK3ß can phosphorylate LCRMP-1 at Thr-628 in consensus sequences and this phosphorylation is crucial for function of LCRMP-1 to promote filopodia formation, migration and invasion in cancer cells. Impediment of Thr-628 phosphorylation attenuates the stimulatory effects of LCRMP-1 on filopodia forming, migration and invasion abilities in cancer cells; simultaneously, kinase-dead GSK3ß diminishes regulation of LCRMP-1 on cancer cell invasion. Furthermore, we also found that patients with low-level Ser-9-phosphorylated GSK3ß expression and high-level LCRMP-1 expression have worse overall survival than those with high-level inactive GSK3ß expressions and low-level LCRMP-1 expressions (P<0.0001). Collectively, these results demonstrate that GSK3ß-dependent phosphorylation of LCRMP-1 provides an important mechanism for regulation of LCRMP-1 on cancer cell invasiveness and clinical outcome.
More...
|
|
|
 |
 |
|
|
|
|
|
|
|
|